Literature DB >> 20042505

Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu.

Tiffany M Lucas1, Terri D Lyddon, Paula M Cannon, Marc C Johnson.   

Abstract

The Env protein from gibbon ape leukemia virus (GaLV) has been shown to be incompatible with human immunodeficiency virus type 1 (HIV-1) in the production of infectious pseudotyped particles. This incompatibility has been mapped to the C-terminal cytoplasmic tail of GaLV Env. Surprisingly, we found that the HIV-1 accessory protein Vpu modulates this incompatibility. The infectivity of HIV-1 pseudotyped with murine leukemia virus (MLV) Env was not affected by Vpu. However, the infectivity of HIV-1 pseudotyped with an MLV Env with the cytoplasmic tail from GaLV Env (MLV/GaLV Env) was restricted 50- to 100-fold by Vpu. A Vpu mutant containing a scrambled membrane-spanning domain, Vpu(RD), was still able to restrict MLV/GaLV Env, but mutation of the serine residues at positions 52 and 56 completely alleviated the restriction. Loss of infectivity appeared to be caused by reduced MLV/GaLV Env incorporation into viral particles. The mechanism of this downmodulation appears to be distinct from Vpu-mediated CD4 downmodulation because Vpu-expressing cells that failed to produce infectious HIV-1 particles nonetheless continued to display robust surface MLV/GaLV Env expression. In addition, if MLV and HIV-1 were simultaneously introduced into the same cells, only the HIV-1 particle infectivity was restricted by Vpu. Collectively, these data suggest that Vpu modulates the cellular distribution of MLV/GaLV Env, preventing its recruitment to HIV-1 budding sites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042505      PMCID: PMC2826068          DOI: 10.1128/JVI.01562-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping.

Authors:  Rebecca L Jorgenson; Volker M Vogt; Marc C Johnson
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

2.  Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.

Authors:  J Stitz; C J Buchholz; M Engelstädter; W Uckert; U Bloemer; I Schmitt; K Cichutek
Journal:  Virology       Date:  2000-07-20       Impact factor: 3.616

3.  Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors.

Authors:  I Christodoulopoulos; P M Cannon
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.

Authors:  Janet L Douglas; Kasinath Viswanathan; Matthew N McCarroll; Jean K Gustin; Klaus Früh; Ashlee V Moses
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

5.  The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.

Authors:  Liwei Rong; Jianyong Zhang; Jennifer Lu; Qinghua Pan; René-Pierre Lorgeoux; Claudette Aloysius; Fei Guo; Shan-Lu Liu; Mark A Wainberg; Chen Liang
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

6.  Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion.

Authors:  Eri Miyagi; Amy J Andrew; Sandra Kao; Klaus Strebel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

7.  Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.

Authors:  Matthew W McNatt; Trinity Zang; Theodora Hatziioannou; Mackenzie Bartlett; Ismael Ben Fofana; Welkin E Johnson; Stuart J D Neil; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2009-02-13       Impact factor: 6.823

8.  HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.

Authors:  Bastien Mangeat; Gustavo Gers-Huber; Martin Lehmann; Madeleine Zufferey; Jeremy Luban; Vincent Piguet
Journal:  PLoS Pathog       Date:  2009-09-04       Impact factor: 6.823

9.  Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.

Authors:  Richard S Mitchell; Chris Katsura; Mark A Skasko; Katie Fitzpatrick; David Lau; Autumn Ruiz; Edward B Stephens; Florence Margottin-Goguet; Richard Benarous; John C Guatelli
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

10.  Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.

Authors:  Ravindra K Gupta; Stéphane Hué; Torsten Schaller; Ernst Verschoor; Deenan Pillay; Greg J Towers
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

View more
  12 in total

1.  Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.

Authors:  Yul Eum Song; Grace Y Olinger; Sanath Kumar Janaka; Marc C Johnson
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

2.  Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.

Authors:  Devon A Gregory; Terri D Lyddon; Marc C Johnson
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

3.  Sequences in gibbon ape leukemia virus envelope that confer sensitivity to HIV-1 accessory protein Vpu.

Authors:  Sanath Kumar Janaka; Tiffany M Lucas; Marc C Johnson
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

4.  Two distinct mechanisms regulate recruitment of murine leukemia virus envelope protein to retroviral assembly sites.

Authors:  Tiffany M Lucas; Terri D Lyddon; Sarah A Grosse; Marc C Johnson
Journal:  Virology       Date:  2010-07-23       Impact factor: 3.616

Review 5.  Mechanisms for Env glycoprotein acquisition by retroviruses.

Authors:  Marc C Johnson
Journal:  AIDS Res Hum Retroviruses       Date:  2011-02-22       Impact factor: 2.205

6.  Improving correlation of wastewater SARS-CoV-2 gene copy numbers with COVID-19 public health cases using readily available biomarkers.

Authors:  Justin M Hutchison; Zhengxi Li; Chi-Ning Chang; Yasawantha Hiripitiyage; Megan Wittman; Belinda S M Sturm
Journal:  FEMS Microbes       Date:  2022-04-01

7.  Diphtheria Toxin A-Resistant Cell Lines Enable Robust Production and Evaluation of DTA-Encoding Lentiviruses.

Authors:  Margaret J Lange; Terri D Lyddon; Marc C Johnson
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

8.  Vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the Vpu cytoplasmic tail.

Authors:  Tiffany M Lucas; Sanath K Janaka; Edward B Stephens; Marc C Johnson
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

9.  Functional complementation of a model target to study Vpu sensitivity.

Authors:  Sanath Kumar Janaka; Jared Faurot; Marc C Johnson
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

10.  βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin.

Authors:  Yul Eum Song; Daniel Cyburt; Tiffany M Lucas; Devon A Gregory; Terri D Lyddon; Marc C Johnson
Journal:  Viruses       Date:  2018-10-19       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.